Monday, November 2, 2026

Micron's Entire 2026 HBM Output Is Already Sold Out as AI Demand Outpaces Supply

Micron's Q3 FY2026 revenue guidance of ~$33.5 billion would surpass any full prior fiscal year. Its HBM supply for all of calendar 2026 is already committed. Sandisk shares have surged over 700% year-to-date, yet both stocks trade at just 10–11x forward earnings.

LM Salvado
LM Salvado

June 19, 2026

Micron's Entire 2026 HBM Output Is Already Sold Out as AI Demand Outpaces Supply
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

Micron's Q3 FY2026 revenue guidance of approximately $33.5 billion would exceed the company's revenue for any full prior fiscal year.1 Its high-bandwidth memory output for all of calendar year 2026 is already sold out.1 Supply, not demand, is now the binding constraint.

Micron has begun shipping HBM for Nvidia's Vera Rubin platform, marking its entry into next-generation AI infrastructure.1 That ramp signals a transition point: AI hardware suppliers are not chasing demand — they are rationing it.

Sandisk shares have risen more than 700% year-to-date in 2026.1 Micron crossed a $1 trillion market capitalization.1 Despite those gains, both companies trade at forward price-to-earnings multiples of approximately 10 to 11 times.1 Earnings are growing faster than share prices.

Sandisk's CEO has identified inference and reasoning workloads as the fastest-growing segment in data center demand.1 That category is structurally different from training workloads. Inference runs continuously at scale, generating persistent storage and memory throughput requirements that compound over time.

The investment case rests on a specific dynamic: when supply is sold out and demand is accelerating, average selling prices stay elevated. Margin expansion follows. Both Micron and Sandisk are operating in that window now, and forward guidance suggests it continues through at least 2027.1

Key variables to monitor: whether Micron announces additional HBM capacity expansions, whether multi-year hyperscaler supply contracts are renewed or extended, and whether gross margins remain elevated over the next four quarters. If HBM ASPs hold and supply stays committed, the revenue trajectory is durable.

At current valuations, the market is pricing in strong earnings but not yet pricing in a prolonged supercycle. If the supply constraint persists into 2027, forward multiples compress further — making both stocks cheaper as they rise.

In this story · Knowledge Files

About this analysis

This is a Via News analysis. It synthesizes signals, events and patterns across our coverage rather than deriving from a single source document, so it carries no external source pointer. Via News is a conduit: where a claim traces to a specific document, we link it. How we source

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic AI Goes Operational: Platform Governance, Local Silicon, and the Physical-AI Data Race
In mid-to-late October 2026, enterprise vendors (Cisco, Fortinet, ServiceNow, Intuit, Salesforce/Braze, Adobe) shipped agent governance, AI security and AI-driven customer engagement products, while a parallel hardware wave (NVIDIA RTX Spark laptops, ASUS, Apple's iPad mini, Microsoft's hybrid local/cloud Windows) pushed AI onto local devices. A third strand, physical AI (Encord, Harvest Praxis, Hesai), argues that real-world sensor data and cheaper edge chips are the next bottleneck. The common thread is the shift from AI experimentation to governed, scaled deployment, with Salesforce's Braze acquisition showing consolidation and fintech players like Intuit tying AI to trusted financial data. The facts support a broad industry theme but contain little direct finance or regulatory evidence, so the AI-finance angle is thin.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,533 source documents archived
Query this data → isubstrate.com